Pictet Asset Management Holding SA
Position in NBIX — Neurocrine Biosciences Inc
CIK 1993888
CAROUGE, V8
Position in NBIX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$72,579,222
-$6,812,966 QoQ
Shares Held
430,635
-28.5% QoQ
Ownership
0.424%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#45
of 768 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pictet Asset Management Holding SA holds $456,869,338 across 25 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
267,852 | $145,130,249 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
430,635 | $72,579,222 | |
| 3 | ALKS |
Alkermes plc.
|
838,026 | $43,908,372 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
608,650 | $38,923,167 | |
| 5 | VTRS |
Viatris Inc
|
2,437,987 | $38,715,233 | |
| 6 | ZTS |
Zoetis Inc.
|
514,723 | $36,987,994 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
432,478 | $20,114,551 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
544,494 | $18,447,456 |
All Filings in NBIX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,579,222 | 430,635 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $79,392,188 | 602,643 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $110,192,549 | 776,934 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $97,345,949 | 693,446 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $87,495,574 | 696,122 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $42,865,684 | 387,574 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $83,417,743 | 611,119 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $97,037,938 | 842,197 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $119,955,175 | 871,324 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $149,153,446 | 1,081,449 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $159,866,120 | 1,213,313 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $117,388,125 | 1,043,450 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||